Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Institute for NanoBioTechnology at Johns Hopkins University; Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR) at University of Virginia; Institute for Soldier Nanotechnologies at MIT; International Institute for Nanotechnology at Northwestern University; Kavli Institute at Cornell for Nanoscale Science
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Best Companies To Invest In Now. Some of these are more defensive stocks that should continue to hold up well in a tough economy, while others are quality companies that have been pummeled and ...
This category contains for-profit companies primarily focused on nanotechnology, from across the world. For non-profit and educational institutions, see Category:Nanotechnology institutions . Subcategories
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online.
SoFi was founded in 2011 as a student loan refinancing company. In 2019, SoFi — , short for Social Finance — expanded into investment services, offering a user-friendly platform to new investors.
The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022. [14] On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.